Life Science Instrumentation Market worth $92.53 billion by 2031
The report "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) - Global Forecast to 2031" is projected to reach USD 92.53 billion by 2031 from USD 63.40 billion in 2025, at a CAGR of 6.5% from 2025 to 2031.
Browse 600 market data Tables and 60 Figures spread through 500 Pages and in-depth TOC on "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html
The growth of this market is primarily driven by the increasing need for advanced analytical technologies to ensure product safety and quality across pharma-biopharma and food industries, alongside rising global investments in research and development. The growing adoption of automation, digitalization, and high-throughput systems is enhancing efficiency and precision in laboratories, while stronger public–private partnerships are accelerating innovation and commercialization of new technologies. In addition, expanding healthcare infrastructure, rapid industrialization, and improved regulatory frameworks in emerging economies are creating new avenues for demand. The rising prevalence of chronic and infectious diseases is further driving the need for sophisticated diagnostic and research tools, positioning the market for sustained expansion in the near future.
The spectroscopy segment is expected to register a significant growth rate over the forecast period.
By technology, the life science instrumentation market is segmented into spectroscopy, chromatography, polymerase chain reaction (quantitative PCR, digital PCR), immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing, centrifuges, electrophoresis, cell counting, and other technologies. The spectroscopy segment held the largest share of the life science instrumentation market in 2025. The growth of spectroscopy technology in life science instrumentation is largely driven by the rising need for accurate molecular characterization and detailed biomolecular analysis in both research and diagnostic settings. Continuous advancements in high-resolution detectors, laser systems, and automation are enhancing the sensitivity, precision, and throughput of analytical processes. Additionally, the expanding research focus on proteomics, metabolomics, and structural biology is accelerating the adoption of advanced spectroscopic techniques, including mass spectrometry, Raman spectroscopy, and infrared spectroscopy, for in-depth chemical and biological analysis.
The research applications segment accounted for the largest share of the life science instrumentation market, by application, in 2025.
By application, the life science instrumentation market is segmented into research applications, clinical & diagnostic applications, and other applications. The research applications segment held the largest share of the life science instrumentation market in 2025. A key trend shaping the life science instrumentation market is the growing focus on advanced research applications, particularly in genomics, proteomics, and metabolomics, which require highly sophisticated analytical and imaging technologies to study complex biological systems. This trend is further supported by increased funding from government bodies and academic institutions, as well as expanding collaborations between research organizations and the biopharmaceutical industry. Together, these factors are driving the adoption of cutting-edge life science instruments and contributing to overall market growth.
The pharmaceutical & biotechnology companies segment accounted for the largest share of the life science instrumentation market, by end user, in 2025.
By end user, the life science instrumentation market is segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries, environmental testing laboratories, clinical research organizations, and other end users. The pharmaceutical & biotechnology companies segment held the largest share of the life science instrumentation market in 2025. The growing prominence of biologics, biosimilars, and personalized medicine has further increased demand for highly precise instruments for proteomics, genomics, and cell analysis. Moreover, rising regulatory requirements for data accuracy and product safety, along with advances in automation, high-throughput screening, and digital analytics, are fostering greater investment in advanced, sophisticated instrumentation.
The Asia Pacific market is expected to register the highest growth in the market during the forecast period.
The Asia Pacific life science instrumentation market is projected to record the highest growth from 2025 to 2031, driven by rapid advancements in biotechnology, pharmaceuticals, and academic research. Major industry players are expanding their manufacturing and R&D capabilities across countries such as China, India, Japan, and South Korea to meet the growing regional demand. Increasing government funding for life science research, rising healthcare expenditures, and the establishment of biopharma manufacturing hubs are further fueling market expansion. Additionally, the growing adoption of analytical and diagnostic instruments in clinical laboratories, coupled with a shift toward precision medicine and automation, is creating significant growth opportunities for global and regional players operating in the APAC life science instrumentation market.
As of 2025, prominent players in the life science instrumentation market are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and Hitachi High-Technologies Corporation (Japan), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Life Science Instrumentation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
